Acute exposure to rosiglitazone does nletb, Asinkich, B
rosiglitazone (1 or 10 mol/L), 5-aminoimidazole-4-carboxamide 1--D-ribonucleoside (1 mmol/L), insulin (120 nmol/L), or a combinationof insulin (120 nmol/L) and rosiglitazone (10 mol/L) in vitro for 1 hour. Glucose transport was analyzed by accumulation of intracellular 3-
develops [2,3]. Therefore, interventions to improve muscle sensitivity in insulin-resistant subjects such as people with
to TZDs directly activates adenosine monophosphateactivated protein kinase (AMPK) and increases glucose
Available online at www.sciencedirect.com
Metabolism Clinical and Experimenta
Corresponding author. Division of Cardiology, Department of
Medicine, Helsinki University Central Hospital; Minerva FoundationInstitute for Medical Research, Biomedicum 2U Helsinki, Tukholmankatuglucose metabolism would be beneficial in the preventionand treatment of type 2 diabetes mellitus. Thiazolidinediones(TZDs), such as rosiglitazone or pioglitazone, are widelyused as antidiabetic drugs . Thiazolidinediones improvewhole-body insulin sensitivity by targeting peroxisomeproliferatoractivated receptor (PPAR), a transcriptionfactor highly expressed in adipocytes . Activation of
obesity, type 2 diabetes mellitus, polycystic ovary disease, orimpaired glucose tolerance (IGT) [7-9].
The PPAR expression in adipocytes is viewed as theprimary target of TZD action . However, it is possible thatTZDs have direct metabolic effects on other tissues such asskeletal muscle and liver, which may be independent ofPPAR. Transgenic mice with no adipose tissue or with amuscle-specific PPAR deletion improve their insulinsensitivity in response to TZDs [10,11], and acute exposureO-methyl [3H] glucose; phosphorylation of Akt-Ser473 and Akt-Thr308 and phosphorylation of acetyl coenzyme A carboxylase weredetermined using phosphospecific antibodies. 5-Aminoimidazole-4-carboxamide 1--D-ribonucleoside and insulin increased glucosetransport rate 1.5-fold (P b .05) and 1.7-fold (P b .01) in isolated muscle strips, respectively. Exposure to rosiglitazone transiently increasedphosphorylation of acetyl coenzyme A carboxylase , with a maximum effect at 15 minutes and return to baseline at 60 minutes. However,rosiglitazone did not affect basal or insulin-stimulated glucose transport rate, or phosphorylation of Akt-Ser473 or Akt-Thr308 in isolatedmuscle strips. In conclusion, acute exposure to rosiglitazone does not affect glucose transport in human skeletal muscle. 2010 Elsevier Inc. All rights reserved.
Skeletal muscle is the main site of resistance to insulin-stimulated glucose metabolism in type 2 diabetes mellitus, and defects at the level of muscle glucose metabolismcan be observed years before overt type 2 diabetes mellitus
PPAR leads to transcriptional changes in a number of genesregulating adipogenesis and fatty acid uptake and storage.This leads to repartition of lipids from circulation, muscle,and liver into adipose tissue, resulting in improved insulinsensitivity [5,6]. Indeed, a number of clinical studies provideevidence that treatment with TZDs improves insulinhuman skePaulina Skrobuka,b, Heidi Kuoppamaaa,
aDivision of Cardiology, Department of Medicine, HelbMinerva Foundation Institute for Medical Resear
Received 27 May 20
Thiazolidinediones (TZDs) such as rosiglitazone are widely usedmetabolic actions in skeletal muscle. Here, we examined if acuteproximal insulin signaling in isolated skeletal muscle strips fromvastus lateralis from 15 nondiabetic men (50 3 years old, 26.8, 00290 Helsinki, Finland. Tel.: +358 9 191 25 710.E-mail address: email@example.com (H.A. Koistinen).
0026-0495/$ see front matter 2010 Elsevier Inc. All rights reserved.doi:10.1016/j.metabol.2009.07.016ot affect glucose transport in intactal musclenne Hiukkaa, Heikki A. Koistinena,b,
University Central Hospital, 00290 Helsinki, Finlandiomedicum 2U Helsinki, 00290 Helsinki, Finland
cepted 16 July 2009
tidiabetic drugs. Animal studies suggest that TZDs may have directsure to rosiglitazone stimulates glucose transport rate and affectsiabetic men. Open muscle biopsies were obtained from musculus1.1 kg/m2). Skeletal muscle strips were isolated and exposed to
l 59 (2010) 224230www.metabolismjournal.comuptake and palmitate oxidation in intact skeletal muscle fromrodents . Clinically, full therapeutic effect is reached
after treatment with TZDs for several weeks to months,demonstrating a delayed onset of action [13-15]. However,LeBrasseur et al  demonstrated that an exposure for asshort as 30 minutes to troglitazone increased glucose uptakein isolated rat skeletal muscle. It is not known if TZDs exertacute direct metabolic effects in intact human skeletalmuscle. Therefore, we examined whether rosiglitazoneaffects glucose transport and proximal insulin-signalingevents in isolated skeletal muscle strips from nondiabeticmen. Because we have previously shown that an acuteactivation of AMPK by the nucleoside analog 5-aminoimi-dazole-4-carboxamide 1--D-ribonucleoside (AICAR)increases glucose transport rate in isolated human skeletalmuscle strips , we also included AICAR exposure in ourexperiments as a positive control.
The study protocol was reviewed and approved by theEthical Committee of the Department of Medicine, HelsinkiUniversity Central Hospital; and written informed consentwas obtained from all subjects before participation. Physio-logic characteristics of the study subjects (15 nondiabetic
Hip (cm) 100 2
225P. Skrobuk et al. / Metabolism Clinical and Experimental 59 (2010) 224230Waist-to-hip ratio 0.97 0.02Body fat % 22.8 1.5VO2max (mL kg
1 min1) 35.8 2.9Systolic blood pressure (mm Hg) 146 5Diastolic blood pressure (mm Hg) 89 3Blood glucose (mmol/L) 5.1 0.1HbA1c (%) 5.2 0.1Serum cholesterol (mmol/L) 4.7 0.2Serum triacylglycerol (mmol/L) 1.6 0.2Serum HDL cholesterol (mmol/L) 1.30 0.08Serum LDL cholesterol (mmol/L) 2.7 0.2Fasting blood glucose at OGTT (mmol/L) 5.3 0.12-h blood glucose at OGTT (mmol/L) 5.3 0.4
Blood samples were obtained for clinical chemistry analysis from fastedmen. Results are means SE. N = 15 except for body fat percentage (n =11) and VO2max (n = 10). HbA1c indicates hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; OGTT, oral glucosetolerance test.men) are presented in Table 1. Six of the men had no familyhistory of diabetes, whereas 9 men had first- and/or second-degree relatives with type 2 diabetes mellitus. Oral glucosetolerance test (75 g) was performed in all subjects. Nine menhad normal glucose tolerance (NGT), 3 men had impairedfasting glucose (IFG), and 3 men had IGT. None of the menwas taking any regular medications. One man was a smoker.All subjects were instructed to avoid strenuous exercise for
Table 1Subject characteristics and clinical chemistry
N 15Age (y) 50 3BMI (kg/m2) 26.9 1.1Waist (cm) 97 372 hours before the muscle biopsy. The subjects wereexamined after an overnight fast.
2.1. Open muscle biopsy
Open biopsies were taken from the vastus lateralismuscle under local anesthesia (lidocaine hydrochloride, 5mg/mL), as previously described [16,17]. A 4-cm incisionwas made 15 cm above the proximal border of patella, andthe muscle fascia was exposed. Thereafter, 4 to 5 musclefiber bundles were excised and placed in oxygenated Krebs-Henseleit buffer (KHB), which contained 5 mmol/LHEPES, 5 mmol/L glucose, 15 mmol/L mannitol, and0.1% bovine serum albumin (radioimmunoassay grade;Sigma, St Louis, MO). Smaller skeletal muscle strips weredissected from the muscle biopsy specimen, mounted onPlexiglass clamps, and incubated in vitro in pregassed (95%O2 and 5% CO2) KHB in shaking water bath at 35C. Thegas phase in the vials was maintained during the incubationprocedure. After 30 minutes of incubation in KHB, skeletalmuscle strips were incubated for 30 minutes at 35C without(basal) or with 1 or 10 mol/L rosiglitazone (AlexisBiochemicals, Lausen, Switzerland), 120 nmol/L insulin(Actrapid; Novo Nordisk A/S, Bagsvrd, Denmark), acombination of 10 mol/L rosiglitazone and insulin, or 1mmol/L AICAR (Sigma). These concentrations weremaintained throughout the subsequent incubation proce-dures. As rosiglitazone was dissolved in methanol, equalamounts of methanol were added to the media to maintainconcentration at 0.1% in all conditions.
2.2. Glucose transport
Skeletal muscle strips were transferred to fresh KHBcontaining 20 mmol/L mannitol and incubated for 10minutes. Subsequently, muscles were incubated for 20minutes in KHB containing 5 mmol/L 3-O-methyl [3H]glucose (800 Ci/mmol) and 15 mmol/L [14C] mannitol(53 Ci/mmol) (GE Healthcare, Life Sciences, Whitchurch,Cardiff, United Kingdom). Muscle strips were blotted ofexcess fluid, frozen in liquid nitrogen, and stored at 80Cuntil further analysis. Glucose transport was determined bythe accumulation of intracellular 3-O-methyl [3H] glucose,as described .
2.3. Tissue processing
Muscle strips were homogenized in ice-cold homogeni-zation buffer (90 L/g dry weight muscle) (20 mmol/L Tris[pH 7.8], 137 mmol/L NaCl, 2.7 mmol/L KCl, 1 mmol/LMgCl2,, 1% Triton X-100, 10% [wt/vol] glycerol, 10 mmol/L NaF, 0.5 mmol/L Na3VO4, 1 g/mL leupeptin, 0.2 mmol/L phenylmethyl sulfonyl fluoride, 1 g/mL aprotinin).Homogenates were rotated for 60 minutes at 4C. Subse-quently, homogenates were subjected to centrifugation(12 000g for 10 minutes at 4C); and protein concentrationwas determined using a bicinchoninic acid protein assay(Pierce, Rockford, IL). An aliquot of homogenate was mixed